BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 32064671)

  • 1. TCR repertoire analysis reveals phosphoantigen-induced polyclonal proliferation of Vγ9Vδ2 T cells in neonates and adults.
    Fichtner AS; Bubke A; Rampoldi F; Wilharm A; Tan L; Steinbrück L; Schultze-Florey C; von Kaisenberg C; Prinz I; Herrmann T; Ravens S
    J Leukoc Biol; 2020 Jun; 107(6):1023-1032. PubMed ID: 32064671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial exposure drives polyclonal expansion of innate γδ T cells immediately after birth.
    Ravens S; Fichtner AS; Willers M; Torkornoo D; Pirr S; Schöning J; Deseke M; Sandrock I; Bubke A; Wilharm A; Dodoo D; Egyir B; Flanagan KL; Steinbrück L; Dickinson P; Ghazal P; Adu B; Viemann D; Prinz I
    Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18649-18660. PubMed ID: 32690687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpaca (
    Fichtner AS; Karunakaran MM; Gu S; Boughter CT; Borowska MT; Starick L; Nöhren A; Göbel TW; Adams EJ; Herrmann T
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6697-6707. PubMed ID: 32139608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire.
    Dimova T; Brouwer M; Gosselin F; Tassignon J; Leo O; Donner C; Marchant A; Vermijlen D
    Proc Natl Acad Sci U S A; 2015 Feb; 112(6):E556-65. PubMed ID: 25617367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation.
    Starick L; Riano F; Karunakaran MM; Kunzmann V; Li J; Kreiss M; Amslinger S; Scotet E; Olive D; De Libero G; Herrmann T
    Eur J Immunol; 2017 Jun; 47(6):982-992. PubMed ID: 28386905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Selection of the Human Vγ9Vδ2
    Willcox CR; Davey MS; Willcox BE
    Front Immunol; 2018; 9():1501. PubMed ID: 30013562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fetal wave of human type 3 effector γδ cells with restricted TCR diversity persists into adulthood.
    Tan L; Fichtner AS; Bruni E; Odak I; Sandrock I; Bubke A; Borchers A; Schultze-Florey C; Koenecke C; Förster R; Jarek M; von Kaisenberg C; Schulz A; Chu X; Zhang B; Li Y; Panzer U; Krebs CF; Ravens S; Prinz I
    Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33893173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal public Vγ9Vδ2 T cells expand and gain potent cytotoxic functions early after birth.
    Papadopoulou M; Dimova T; Shey M; Briel L; Veldtsman H; Khomba N; Africa H; Steyn M; Hanekom WA; Scriba TJ; Nemes E; Vermijlen D
    Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18638-18648. PubMed ID: 32665435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome Signature of Vγ9Vδ2 T Cells Treated With Phosphoantigens and Notch Inhibitor Reveals Interplay Between TCR and Notch Signaling Pathways.
    Madhok A; Bhat SA; Philip CS; Sureshbabu SK; Chiplunkar S; Galande S
    Front Immunol; 2021; 12():660361. PubMed ID: 34526984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic pattern analyses of Vδ2
    Deng L; Harms A; Ravens S; Prinz I; Tan L
    Front Immunol; 2022; 13():960920. PubMed ID: 36275749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model.
    Sicard H; Ingoure S; Luciani B; Serraz C; Fournié JJ; Bonneville M; Tiollier J; Romagné F
    J Immunol; 2005 Oct; 175(8):5471-80. PubMed ID: 16210655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-23R and TCR signaling drives the generation of neonatal Vgamma9Vdelta2 T cells expressing high levels of cytotoxic mediators and producing IFN-gamma and IL-17.
    Moens E; Brouwer M; Dimova T; Goldman M; Willems F; Vermijlen D
    J Leukoc Biol; 2011 May; 89(5):743-52. PubMed ID: 21330350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vγ9Vδ2 TCR-activation by phosphorylated antigens requires butyrophilin 3 A1 (BTN3A1) and additional genes on human chromosome 6.
    Riaño F; Karunakaran MM; Starick L; Li J; Scholz CJ; Kunzmann V; Olive D; Amslinger S; Herrmann T
    Eur J Immunol; 2014 Sep; 44(9):2571-6. PubMed ID: 24890657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins.
    Laplagne C; Ligat L; Foote J; Lopez F; Fournié JJ; Laurent C; Valitutti S; Poupot M
    Cell Mol Immunol; 2021 Aug; 18(8):1861-1870. PubMed ID: 34183807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCR Sequencing Reveals the Distinct Development of Fetal and Adult Human Vγ9Vδ2 T Cells.
    Papadopoulou M; Tieppo P; McGovern N; Gosselin F; Chan JKY; Goetgeluk G; Dauby N; Cogan A; Donner C; Ginhoux F; Vandekerckhove B; Vermijlen D
    J Immunol; 2019 Sep; 203(6):1468-1479. PubMed ID: 31413106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD70-CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human γδ peripheral blood lymphocytes.
    DeBarros A; Chaves-Ferreira M; d'Orey F; Ribot JC; Silva-Santos B
    Eur J Immunol; 2011 Jan; 41(1):195-201. PubMed ID: 21182090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells.
    Peigné CM; Léger A; Gesnel MC; Konczak F; Olive D; Bonneville M; Breathnach R; Scotet E
    J Immunol; 2017 Jun; 198(11):4228-4234. PubMed ID: 28461569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
    Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
    J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Armadillo (
    Fichtner AS; Karunakaran MM; Starick L; Truman RW; Herrmann T
    Front Immunol; 2018; 9():265. PubMed ID: 29527206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vγ9Vδ2 T Cells Activation Through Phosphoantigens Can Be Impaired by a RHOB Rerouting in Lung Cancer.
    Laplagne C; Meddour S; Figarol S; Michelas M; Calvayrac O; Favre G; Laurent C; Fournié JJ; Cabantous S; Poupot M
    Front Immunol; 2020; 11():1396. PubMed ID: 32733462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.